Sign in

    Jon Win

    Research Analyst at UBS

    Jon Win is an Executive Director and Equity Research Analyst at UBS, specializing in the coverage of the semiconductor and hardware technology sectors. He provides analysis on major publicly traded companies including NVIDIA, AMD, Intel, and Micron, with his investment recommendations consistently tracked on platforms such as TipRanks where he maintains a strong success rate and robust average returns relative to peers. Jon began his career in equity research after earning his MBA, previously holding analyst roles at two other global investment banks before joining UBS in 2018. He holds FINRA Series 7, 63, and 86/87 securities licenses, underscoring his professional credentials in the investment research domain.

    Jon Win's questions to AbbVie (ABBV) leadership

    Jon Win's questions to AbbVie (ABBV) leadership • Q4 2024

    Question

    An analyst from UBS asked if there were any notable Q4 trends in stocking or gross-to-net patterns ahead of the Part D changes and requested more geographic color on the expected aesthetics recovery, particularly the U.S. versus China.

    Answer

    EVP & CFO Scott Reents stated there was minimal stocking impact in Q4 and no unusual gross-to-net dynamics for Skyrizi and Rinvoq. SVP Carrie Strom explained that while the U.S. and China remain key markets, Japan is also a growth driver. She noted that new product launches in China are helping drive share and expects the international business to increase as a percentage of total aesthetics revenue over time.

    Ask Fintool Equity Research AI